{"content":"<li class=\"n-box-item date-title\" data-end=\"1481345999\" data-start=\"1481259600\" data-txt=\"Sunday, December 22, 2019\">Friday, December  9, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3229837\" data-ts=\"1481322976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229837-activate-founder-and-t-time-warner-makes-consumer-sense\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Activate founder: AT&amp;T/Time Warner makes consumer sense</a></h4><ul>   <li>AT&amp;T's (<a href=\"https://seekingalpha.com/symbol/T\" title=\"AT&amp;T Inc.\">T</a> <font color=\"red\">-0.1%</font>) deal to acquire Time Warner (<a href=\"https://seekingalpha.com/symbol/TWX\" title=\"Time Warner Inc.\">TWX</a> <font color=\"green\">+0.7%</font>) <a href=\"http://www.broadcastingcable.com/news/washington/michael-wolf-att-time-warner-deal-consumer-friendly/161714\" target=\"_blank\">adds up for consumers</a>, according to Activate founder Michael Wolf.</li>    <li>Wolf, formerly chief operating officer of MTV Networks, thinks the deal can go forward even with previous threats from president-elect Donald Trump about blocking it.</li>    <li>\"This deal makes a lot of sense from a consumer perspective,\" Wolf says. \"It's not taking away any real control of voices in the Internet or in media.\"</li>    <li>Helping AT&amp;T's cause there: a likely rollback of power at the FCC, which has authority over many deals with a mandate for the best interest of consumers.</li>    <li>Broadcasters like Sinclair (<a href=\"https://seekingalpha.com/symbol/SBGI\" title=\"Sinclair Broadcast Group, Inc.\">SBGI</a> <font color=\"red\">-1.9%</font>) are also likely to be able to buy more stations despite being up against an ownership limit today, Wolf says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229837\" data-linked=\"Activate founder: AT&amp;T/Time Warner makes consumer sense\" data-tweet=\"$T $T $TWX - Activate founder: AT&amp;T/Time Warner makes consumer sense https://seekingalpha.com/news/3229837-activate-founder-and-t-time-warner-makes-consumer-sense?source=tweet\" data-url=\"https://seekingalpha.com/news/3229837-activate-founder-and-t-time-warner-makes-consumer-sense\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229836\" data-ts=\"1481322959\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229836-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:&nbsp;</b><a href='https://seekingalpha.com/symbol/WTI' title='W&T Offshore, Inc.'>WTI</a> <font color='green'>+3.6%</font>. <a href='https://seekingalpha.com/symbol/BMRN' title='BioMarin Pharmaceutical Inc.'>BMRN</a> <font color='green'>+1.2%</font>. EOCC <font color='green'>+1.2%</font>. <a href='https://seekingalpha.com/symbol/JAZZ' title='Jazz Pharmaceuticals, Inc.'>JAZZ</a> <font color='green'>+1.1%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a> <font color='red'>-2.1%</font>. <a href='https://seekingalpha.com/symbol/RDC' title='Rowan Companies plc'>RDC</a> <font color='red'>-2.0%</font>. <a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a> <font color='red'>-1.7%</font>. <a href='https://seekingalpha.com/symbol/KLIC' title='Kulicke and Soffa Industries, Inc.'>KLIC</a> <font color='red'>-1.3%</font>. <a href='https://seekingalpha.com/symbol/OII' title='Oceaneering International Inc.'>OII</a> <font color='red'>-1.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229836\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$WTI $BMRN $JAZZ - After Hours Gainers / Losers https://seekingalpha.com/news/3229836-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3229836-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229835\" data-ts=\"1481322530\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIVHY\" target=\"_blank\">VIVHY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229835-vivendi-builds-25-stake-in-ubisoft-nears-possible-hostile-buyout-attempt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivendi builds 25% stake in Ubisoft, nears possible hostile buyout attempt</a></h4><ul>   <li>Vivendi (<a href=\"https://seekingalpha.com/symbol/VIVHY\" title=\"Vivendi SA ADR\">OTCPK:VIVHY</a> <font color=\"green\">+5.8%</font>) is edging closer to what could be a hostile takeover of Ubisoft (<a href=\"https://seekingalpha.com/symbol/UBSFY\" title=\"UbiSoft Entertainment Inc. ADR\">OTCPK:UBSFY</a> <font color=\"green\">+1%</font>) after it crested the 25% ownership threshold.</li>    <li>The media giant <a href=\"http://www.vivendi.com/en/press/press-releases/vivendi-exceeded-the-25-shareholding-threshold-in-ubisoft/\" target=\"_blank\">filed a report</a> on crossing 25% capital ownership with securities regulator Autorité des Marchés Financiers. Vivendi, run by mogul Vincent Bollore, holds about 22.92% of Ubisoft voting rights.</li>    <li>The founding Guillemot family has been taking steps all year to fend off increasing ownership by Vivendi. Vivendi had taken 100% control of Gameloft -- also run by the Guillemot family -- this year after <a href=\"https://seekingalpha.com/news/3186396-report-vivendi-votes-control-gameloft\" target=\"_blank\">achieving the votes to control that company</a> in May.</li>    <li>If Vivendi crosses the 30% capital ownership mark, it's required by law to make a buyout offer.</li>    <li>In its filing, Vivendi laid out its \"objectives over the coming six months,\" including: financing acquisitions using disposable cash; not working with any third party on its Ubisoft investment; considering more share purchases of Ubisoft; \"not considering the launch of a public tender on Ubisoft nor acquiring the control of the company\"; and achieving board seats and \"a fruitful cooperation.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229835\" data-linked=\"Vivendi builds 25% stake in Ubisoft, nears possible hostile buyout attempt\" data-tweet=\"$VIVHY $VIVHY $UBSFY - Vivendi builds 25% stake in Ubisoft, nears possible hostile buyout attempt https://seekingalpha.com/news/3229835-vivendi-builds-25-stake-in-ubisoft-nears-possible-hostile-buyout-attempt?source=tweet\" data-url=\"https://seekingalpha.com/news/3229835-vivendi-builds-25-stake-in-ubisoft-nears-possible-hostile-buyout-attempt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229826\" data-ts=\"1481320097\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229826-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li> <b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/GAZ\" title=\"iPath DJ-UBS Natural Gas Total Return Sub-Index ETN\">GAZ</a> <font color=\"green\">+14.2%</font>. <a href=\"https://seekingalpha.com/symbol/URA\" title=\"Global X Uranium ETF\">URA</a> <font color=\"green\">+9.87%</font>. <a href=\"https://seekingalpha.com/symbol/UNG\" title=\"The United States Natural Gas ETF, LP\">UNG</a> <font color=\"green\">+8.27%</font>. <a href=\"https://seekingalpha.com/symbol/TAN\" title=\"Guggenheim Solar ETF\">TAN</a> <font color=\"green\">+6.25%</font>. <a href=\"https://seekingalpha.com/symbol/IJS\" title=\"iShares S&amp;P Small-Cap 600 Value ETF\">IJS</a> <font color=\"green\">+6.16%</font>.  </li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/VXX\" title=\"iPath S&amp;P 500 VIX Short-Term Futures ETN\">VXX</a> <font color=\"red\">-10.35%</font>. <a href=\"https://seekingalpha.com/symbol/GDXJ\" title=\"VanEck Vectors Junior Gold Miners ETF\">GDXJ</a> <font color=\"red\">-3.6%</font>. <a href=\"https://seekingalpha.com/symbol/GDX\" title=\"VanEck Vectors Gold Miners ETF\">GDX</a> <font color=\"red\">-3.28%</font>. <a href=\"https://seekingalpha.com/symbol/PHYS\" title=\"Sprott Physical Gold Trust\">PHYS</a> <font color=\"red\">-1.76%</font>. <a href=\"https://seekingalpha.com/symbol/TLT\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a> <font color=\"red\">-1.75%</font>.   </li> </ul><div class=\"tiny-share-widget\" data-id=\"3229826\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$GAZ-OLD $URA $UNG - Weekly ETF Gainers / Losers https://seekingalpha.com/news/3229826-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3229826-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229817\" data-ts=\"1481317993\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIVE\" target=\"_blank\">LIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229817-live-ventures-completes-reverse-stock-split\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Live Ventures completes reverse stock split</a></h4><ul>   <li>Live Ventures (<a href=\"https://seekingalpha.com/symbol/LIVE\" title=\"Live Ventures\">LIVE</a> <font color=\"red\">-3.4%</font>) has wrapped a 1-for-6 reverse split, which it had undertaken to appeal to institutional investors rather than any Nasdaq compliance reason.</li>    <li>The company's in full compliance with Nasdaq standards, it notes.</li>    <li>The reverse split doesn't affect proportionate voting rights or any other common-stock rights. Fractional shares were rounded up to a full share.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3227016-live-ventures-fire-reverse-split\" target=\"_blank\">Live Ventures to fire off reverse split</a> (Nov. 28 2016)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229817\" data-linked=\"Live Ventures completes reverse stock split\" data-tweet=\"$LIVE - Live Ventures completes reverse stock split https://seekingalpha.com/news/3229817-live-ventures-completes-reverse-stock-split?source=tweet\" data-url=\"https://seekingalpha.com/news/3229817-live-ventures-completes-reverse-stock-split\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229810\" data-ts=\"1481317072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNX\" target=\"_blank\">KNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229810-swift-transportation-selloff-likely-short-lived-deutsche-bank-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Swift Transportation selloff likely short-lived, Deutsche Bank says</a></h4><ul>     <li>Today's selloff in Swift Transportation (SWFT <font color=\"red\">-7.7%</font>) should be \"<a href=\"http://thefly.com/landingPageNews.php?id=2475168&amp;headline=SWFT-Swift-Transport-selloff-likely-relatively-shortlived-says-Deutsche-Bank\" target=\"_blank\">relatively short-lived</a>,\" Deutsche Bank says, as management's update call today was cautious on near-term prospects but cautiously optimistic on the medium term and long term.</li>\n<li>SWFT cut its guidance on FY 2016 EPS to $1.20-$1.30 from a prior $1.30-$1.40, below $1.32 analyst consensus estimate, and Q1 2017 EPS to $0.13-$0.18 vs. $0.24 consensus.</li>     <li>Deutsche Bank analyst Amit Mehrotra calls the call a \"recalibration of near-term expectations after a strong run in shares\" and expects the stock to move back up to his $28 price target as improving trucking conditions emerge; he keeps a Buy rating on the shares.</li>     <li>SWFT notched a fresh YTD high earlier this week amid a broad rally in transportation stocks.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229810\" data-linked=\"Swift Transportation selloff likely short-lived, Deutsche Bank says\" data-tweet=\"$KNX - Swift Transportation selloff likely short-lived, Deutsche Bank says https://seekingalpha.com/news/3229810-swift-transportation-selloff-likely-short-lived-deutsche-bank-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3229810-swift-transportation-selloff-likely-short-lived-deutsche-bank-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229807\" data-ts=\"1481316381\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229807-broadcomplus-4_4-amid-analysts-post-earnings-price-target-bumps\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broadcom +4.4% amid analysts&#39; post-earnings price target bumps</a></h4><ul>   <li>Broadcom (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AVGO\" title=\"Broadcom Limited\">AVGO</a>) -- <font color=\"green\">up 4.4%</font> after its continuing operations marked a solid beat in <a href=\"https://seekingalpha.com/news/3229550-broadcom-plus-2_6-percent-earnings-report-features-beat-doubled-dividend\" target=\"_blank\">yesterday's earnings report</a> -- is seeing <a href=\"http://blogs.barrons.com/techtraderdaily/2016/12/09/broadcom-rising-outlook-rebuts-iphone-worries/\" target=\"_blank\">price target hikes</a> as analysts weigh the impact on the company and on peer wireless players.</li>    <li>B. Riley's Craig Ellis has boosted his price target generously to $235 from $215, implying near-32% upside from today's higher price. Strength should continue in optical and data center, and wireless should see a seasonal drop, falling in the mid-teens (\"about 50% greater than our projection after seasonal tailwinds go from positive to negative\").</li>    <li>Canaccord Genuity analyst Mike Walkley has reiterated a price target of $250, 40% upside. \"Consistent with our iPhone estimates, we believe the strong Broadcom wireless sales that increased 32% sequentially are consistent with our modeling of strong content share gains driving more of the year-over-year sales growth versus iPhone units.\"</li>    <li>Meanwhile, Instinet's Romit Shah boosted his price target to $190 from $180, and Morgan Stanley's Craig Hettenbach reiterated a $210 price target on the stock he calls a \"core holding.\"</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3229758-northland-securities-suggests-broadcoms-q4-indicates-positively-qualcomm-marvell-technology\" target=\"_blank\">Northland Securities suggests Broadcom's Q4 indicates positively for Qualcomm, Marvell Technology, Silicon Motion Technology</a> (Dec. 09 2016)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229807\" data-linked=\"Broadcom +4.4% amid analysts&#39; post-earnings price target bumps\" data-tweet=\"$AVGO - Broadcom +4.4% amid analysts&#39; post-earnings price target bumps https://seekingalpha.com/news/3229807-broadcomplus-4_4-amid-analysts-post-earnings-price-target-bumps?source=tweet\" data-url=\"https://seekingalpha.com/news/3229807-broadcomplus-4_4-amid-analysts-post-earnings-price-target-bumps\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229806\" data-ts=\"1481316180\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CWST\" target=\"_blank\">CWST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229806-casella-wasteminus-5-following-first-analysis-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Casella Waste -5% following First Analysis downgrade</a></h4><ul>\n<li>Casella Waste Systems (<a href=\"https://seekingalpha.com/symbol/CWST\" title=\"Casella Waste Systems, Inc.\">CWST</a> <font color=\"red\">-5.2%</font>) is <a href=\"http://www.streetinsider.com/Downgrades/First+Analysis+Downgrades+Casella+Waste+Systems+%28CWST%29+to+Equal+Weight/12328267.html\" target=\"_blank\">downgraded</a> to Equal Weight from Overweight with a $15 price target at First Analysis Securities following the stock's post-election run higher.</li>\n<li>The firm still likes the company, citing strong progress in improving its operating effectiveness, pricing, free  cash flow and balance sheet, and believes the efforts  will continue to bear fruit in 2017 and beyond, positioning CWST to achieve its 2018 EBITDA and free cash flow targets a year early.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229806\" data-linked=\"Casella Waste -5% following First Analysis downgrade\" data-tweet=\"$CWST - Casella Waste -5% following First Analysis downgrade https://seekingalpha.com/news/3229806-casella-wasteminus-5-following-first-analysis-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3229806-casella-wasteminus-5-following-first-analysis-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229803\" data-ts=\"1481313746\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229803-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/INVN' title='InvenSense'>INVN</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/RNET' title='RigNet'>RNET</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/INVE' title='Identiv, Inc.'>INVE</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/AOSL' title='Alpha and Omega Semiconductor Limited'>AOSL</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SCON' title='Superconductor Technologies Inc.'>SCON</a> <font color='red'>-29%</font>. <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/XTLY' title='Xactly'>XTLY</a> <font color='red'>-20%</font>. COOL <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229803\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$INVN $NIHD $RNET - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3229803-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3229803-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229799\" data-ts=\"1481313469\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWI\" target=\"_blank\">TWI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229799-titan-international-names-reitz-ceo-and-president\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Titan International names Reitz as CEO and President</a></h4><ul>\n<li>Titan International (<a href=\"https://seekingalpha.com/symbol/TWI\" title=\"Titan International Inc.\">TWI</a> <font color=\"red\">-2.5%</font>) appoints Paul Reitz as its new CEO and President, effective Jan. 1, replacing the retiring Maurice Taylor.</li>\n<li>Reitz joined TWI in 2010 as CFO and was promoted to President in 2014; he had been chief accounting officer for  Carmike Cinemas.</li>\n<li>Taylor, who has served the company since its inception in 1983, will continue to serve as Chairman.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229799\" data-linked=\"Titan International names Reitz as CEO and President\" data-tweet=\"$TWI - Titan International names Reitz as CEO and President https://seekingalpha.com/news/3229799-titan-international-names-reitz-ceo-and-president?source=tweet\" data-url=\"https://seekingalpha.com/news/3229799-titan-international-names-reitz-ceo-and-president\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229797\" data-ts=\"1481312405\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229797-biogen-gives-up-gains-on-aducanumab-lte-seizure-patient\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen gives up gains on Aducanumab LTE seizure patient</a></h4><ul>\n<li>The slide presentation at CTAD 2106 notes serious adverse events in two or more patients, \"including one subject with a concurrent SAE of seizure and loss of pulse.\"</li>\n<li>Mizuho's Salim Syed <a href=\"http://www.streetinsider.com/Analyst+Comments/Mizuho+Discusses+Biogen+%28BIIB%29+Seizure+Patient/12329626.html\" target=\"_blank\">says the company wasn't </a>willing to say a lot beyond the slide, but what we do know is the seizure patient also had ARIA. Further, this was a pretty small study, so should there be more events like this expected in Phase 3.</li>\n<li>Jefferies wants to know more, <a href=\"https://pbs.twimg.com/media/CzQfmcBWIAYTd1F.jpg\" target=\"_blank\">but continues to believe safety</a> remains the main risk to the program.</li>\n<li>The safety data look good to RBC, which advises buying on weakness.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/BIIB\" title=\"Biogen Inc.\">BIIB</a><font color=\"red\"> -0.2%</font>\n</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3229659-positive-early-stage-data-alzheimers-candidate-stokes-biogen-shares-4-percent-premarket\" target=\"_blank\">Positive early-stage data on Alzheimer's candidate stokes Biogen; shares up 4% premarket</a> (Dec. 9)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229797\" data-linked=\"Biogen gives up gains on Aducanumab LTE seizure patient\" data-tweet=\"$BIIB - Biogen gives up gains on Aducanumab LTE seizure patient https://seekingalpha.com/news/3229797-biogen-gives-up-gains-on-aducanumab-lte-seizure-patient?source=tweet\" data-url=\"https://seekingalpha.com/news/3229797-biogen-gives-up-gains-on-aducanumab-lte-seizure-patient\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229796\" data-ts=\"1481312327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229796-vale-gets-operating-license-for-s11d-iron-ore-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vale gets operating license for S11D iron ore mine</a></h4><ul>     <li>Brazil's environment regulator <a href=\"http://www.reuters.com/article/vale-mine-license-idUSL1N1E40U4\" target=\"_blank\">approves a 10-year operating license</a> for the S11D iron ore mine being constructed by Vale (<a href=\"https://seekingalpha.com/symbol/VALE\" title=\"Vale S.A.\">VALE</a> <font color=\"red\">-2%</font>).</li>     <li>The mine will have a capacity of 90M metric tons and reasserts Vale's position as the world's top iron ore producer after years of stagnation; it is expected to start operations by year-end, with the first shipment set for January 2017.</li>     <li>The license is \"an important milestone in consolidating Vale's position as the producer with the lowest C1 cash cost in the industry,\" the company says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229796\" data-linked=\"Vale gets operating license for S11D iron ore mine\" data-tweet=\"$VALE - Vale gets operating license for S11D iron ore mine https://seekingalpha.com/news/3229796-vale-gets-operating-license-for-s11d-iron-ore-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/3229796-vale-gets-operating-license-for-s11d-iron-ore-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229793\" data-ts=\"1481311420\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGYP\" target=\"_blank\">SGYP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229793-synergy-pharma-gives-up-big-gains-now-down-nearly-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synergy Pharma gives up big gains, now down nearly 7%</a></h4><ul>\n<li>Investors are selling the news as they mull what's next after Synergy's (<a href=\"https://seekingalpha.com/symbol/SGYP\" title=\"Synergy Pharmaceuticals, Inc.\">SGYP</a> <font color=\"red\">-6.8%</font>) successful <a href=\"https://seekingalpha.com/news/3229690-synergy-pharmas-plecanatide-successful-late-stage-ibs-c-study-shares-ahead-17-percent\" target=\"_blank\">Phase 3 trial for plecanatide</a>. There's another Phase 3 trial, but those results aren't to be released for several weeks.</li>\n<li>Also an issue is who might step up for a buyout given the costs associated with bringing the drug to market.</li>\n<li>Citi's Liav Abraham sees Takeda Pharmaceutical (TKPYY <font color=\"green\">+1.5%</font>) as the most likely buyer in her coverage universe, and the <em>FT</em> today reported the company as willing to spend up to $15B in acquisitions to boost its U.S. presence. Abraham retains her Neutral rating and $4 price target (current price is $5.15).</li>\n<li>Source: <a href=\"http://thefly.com/landingPageNews.php?id=2430680&amp;headline=SGYP;TKPYY-Citi-views-Synergy-Pharmaceuticals-as-potential-target-for-Takeda\" target=\"_blank\">TheFly</a>\n</li>\n<li>Related tickers: Ironwood Pharma (<a href=\"https://seekingalpha.com/symbol/IRWD\" title=\"Ironwood Pharmaceuticals, Inc.\">IRWD</a> <font color=\"green\">+2.3%</font>), Sucampo Pharma (<a href=\"https://seekingalpha.com/symbol/SCMP\" title=\"Sucampo Pharmaceuticals, Inc.\">SCMP</a> <font color=\"green\">+4.3%</font>)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229793\" data-linked=\"Synergy Pharma gives up big gains, now down nearly 7%\" data-tweet=\"$SGYP $SGYP-OLD $TAK - Synergy Pharma gives up big gains, now down nearly 7% https://seekingalpha.com/news/3229793-synergy-pharma-gives-up-big-gains-now-down-nearly-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3229793-synergy-pharma-gives-up-big-gains-now-down-nearly-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>79&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229792\" data-ts=\"1481311339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTE\" target=\"_blank\">PTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229792-majesco-moves-on-polarityte-merger-naming-chief-medical-officer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Majesco moves on PolarityTE merger by naming chief medical officer</a></h4><ul>   <li>Fresh off the announcement of a merger into medical tissue company PolarityTE, videogame maker Majesco Entertainment (<a href=\"https://seekingalpha.com/symbol/COOL\" target=\"_blank\">COOL</a> <font color=\"red\">-11.8%</font>) has named Dr. Michael Neumeister as its chief medical officer.</li>    <li>Neumeister is a veteran plastic and reconstructive surgeon who was formerly president of the Plastic Surgery Foundation and Plastic Surgery Research Council.</li>    <li>When the merger is completed, PolarityTE will operate as a wholly owned subsidiary of Majesco Entertainment, which will change its name to Polarity.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3229438-majesco-entertainment-polarityte-merge\" target=\"_blank\">Majesco Entertainment and PolarityTE to merge</a> (Dec. 08 2016)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229792\" data-linked=\"Majesco moves on PolarityTE merger by naming chief medical officer\" data-tweet=\"$PTE - Majesco moves on PolarityTE merger by naming chief medical officer https://seekingalpha.com/news/3229792-majesco-moves-on-polarityte-merger-naming-chief-medical-officer?source=tweet\" data-url=\"https://seekingalpha.com/news/3229792-majesco-moves-on-polarityte-merger-naming-chief-medical-officer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229791\" data-ts=\"1481311104\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAGDF\" target=\"_blank\">CAGDF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229791-centerra-gold-suspends-dividend-over-kyrgyzstan-dispute\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Centerra Gold suspends dividend over Kyrgyzstan dispute</a></h4><ul>\n<li>Centerra Gold (<a href=\"https://seekingalpha.com/symbol/CAGDF\" title=\"Centerra Gold Inc.\">OTCPK:CAGDF</a> <font color=\"red\">-4.4%</font>) falls as much as 7% after saying it will <a href=\"http://business.financialpost.com/news/mining/centerra-gold-stock-inc-tumbles-after-miner-suspends-dividend-over-kyrgyzstan-dispute\" target=\"_blank\">suspend quarterly dividends</a>, citing financial restrictions by Kyrgyzstan on its Kumtor Gold subsidiary.</li>\n<li>The Kyrgyzstan government has long sought to renegotiate its 2009 agreement with Centerra to secure a bigger share of income, and the company finally took the dispute to international arbitration in May; a Kyrgyzstan court ruling in June restricted Kumtor from making certain financial transactions, including the transfer of money to parent Centerra.</li>\n<li>Given Centerra\u2019s restricted cash flow, RBC analysts say the dividend suspension - which will save $35M/year - is a prudent decision .</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229791\" data-linked=\"Centerra Gold suspends dividend over Kyrgyzstan dispute\" data-tweet=\"$CAGDF - Centerra Gold suspends dividend over Kyrgyzstan dispute https://seekingalpha.com/news/3229791-centerra-gold-suspends-dividend-over-kyrgyzstan-dispute?source=tweet\" data-url=\"https://seekingalpha.com/news/3229791-centerra-gold-suspends-dividend-over-kyrgyzstan-dispute\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229790\" data-ts=\"1481310623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229790-financials-top-5-gainers-losers-of-2-10-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 2:10 PM</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FAC' title='First Acceptance Corporation'>FAC</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/XBKS' title='Xenith Bankshares, Inc.'>XBKS</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CDOR' title='Condor Hospitality Trust, Inc.'>CDOR</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/OVBC' title='Ohio Valley Banc Corp.'>OVBC</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/OZM' title='Och-Ziff Capital Management Group LLC'>OZM</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group'>PMTS</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/PUB' title='People&#39;s Utah Bancorp'>PUB</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229790\" data-linked=\"Financials - Top 5 Gainers / Losers as of 2:10 PM\" data-tweet=\"$FAC $XBKS $CDOR - Financials - Top 5 Gainers / Losers as of 2:10 PM https://seekingalpha.com/news/3229790-financials-top-5-gainers-losers-of-2-10-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3229790-financials-top-5-gainers-losers-of-2-10-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229789\" data-ts=\"1481310612\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229789-energy-materials-top-5-gainers-losers-of-2-10-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:10 pm</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/PACD\" title=\"Pacific Drilling SA\">PACD</a> <font color=\"green\">+20%</font>. SWC <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/SDLP\" title=\"Seadrill Partners, LLC\">SDLP</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/NE\" title=\"Noble Corporation plc\">NE</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/SDRL\" title=\"Seadrill Limited (New)\">SDRL</a> <font color=\"green\">+12%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/SBGL\" title=\"Sibanye-Stillwater\">SBGL</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/NAK\" title=\"Northern Dynasty Minerals Ltd\">NAK</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/PZG\" title=\"Paramount Gold Nevada Corp.\">PZG</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/USAC\" title=\"USA Compression Partners, LP\">USAC</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/TTI\" title=\"Tetra Technologies Inc.\">TTI</a> <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229789\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:10 pm\" data-tweet=\"$PACD $SBGL $SDLPF - Energy/Materials - Top 5 Gainers / Losers as of 2:10 pm https://seekingalpha.com/news/3229789-energy-materials-top-5-gainers-losers-of-2-10-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3229789-energy-materials-top-5-gainers-losers-of-2-10-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229785\" data-ts=\"1481310272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDCO\" target=\"_blank\">MDCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229785-healthcare-bounces-back-from-trump-tantrum\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare bounces back from Trump tantrum</a></h4><ul>\n<li>The healthcare sector - particularly pharmaceuticals and biotechs - had a rough session on Wednesday <a href=\"https://seekingalpha.com/news/3229124-biotech-decline-drug-prices-trump-radar\" target=\"_blank\">after the president-elect</a> promised to bring down drug prices.</li>\n<li>Sporting sizable gains yesterday afternoon and again this session, the sector has recovered all of Wednesday's slide and more.</li>\n<li>\n<font color=\"green\">Up 1.15%</font> today, the <a href=\"https://seekingalpha.com/symbol/XLV\" title=\"Health Care Select Sect SPDR ETF\">XLV</a> has joined the broader market in the green for the week, as has the <a href=\"https://seekingalpha.com/symbol/IBB\" title=\"iShares Nasdaq Biotechnology ETF\">IBB</a>. The SPDR S&amp;P Pharmaceuticals ETF (<a href=\"https://seekingalpha.com/symbol/XPH\" title=\"SPDR S&amp;P Pharmaceuticals ETF\">XPH</a> <font color=\"green\">+1.5%</font>) is having the best day of all, but remains marginally lower on the week.</li>\n<li>Individual movers: The Medicines Co. (<a href=\"https://seekingalpha.com/symbol/MDCO\" title=\"The Medicines Company\">MDCO</a> <font color=\"green\">+6.2%</font>), Alexion Pharma (<a href=\"https://seekingalpha.com/symbol/ALXN\" title=\"Alexion Pharmaceuticals, Inc.\">ALXN</a> <font color=\"green\">+5.5%</font>), Arena Pharma (<a href=\"https://seekingalpha.com/symbol/ARNA\" title=\"Arena Pharmaceuticals, Inc.\">ARNA</a> <font color=\"green\">+4.7%</font>), Teva (<a href=\"https://seekingalpha.com/symbol/TEVA\" title=\"Teva Pharmaceutical Industries Limited\">TEVA</a> <font color=\"green\">+1.3%</font>)</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/IBB\" title=\"iShares Nasdaq Biotechnology ETF\">IBB</a>, <a href=\"https://seekingalpha.com/symbol/XLV\" title=\"Health Care Select Sect SPDR ETF\">XLV</a>, <a href=\"https://seekingalpha.com/symbol/IYH\" title=\"iShares U.S. Healthcare ETF\">IYH</a>, <a href=\"https://seekingalpha.com/symbol/XBI\" title=\"SPDR Biotech ETF\">XBI</a>, <a href=\"https://seekingalpha.com/symbol/VHT\" title=\"Vanguard Health Care ETF\">VHT</a>, <a href=\"https://seekingalpha.com/symbol/PJP\" title=\"Invesco Dynamic Pharmaceuticals Portfolio ETF\">PJP</a>, <a href=\"https://seekingalpha.com/symbol/BBH\" title=\"VanEck Vectors Biotech ETF\">BBH</a>, <a href=\"https://seekingalpha.com/symbol/HQH\" title=\"Tekla Healthcare Investors\">HQH</a>, <a href=\"https://seekingalpha.com/symbol/FBT\" title=\"First Trust NYSE Arca Biotechnology Index ETF\">FBT</a>, <a href=\"https://seekingalpha.com/symbol/CURE\" title=\"Direxion Daily Healthcare Bull 3x Shares ETF\">CURE</a>, <a href=\"https://seekingalpha.com/symbol/HQL\" title=\"Tekla Life Sciences Investors\">HQL</a>, <a href=\"https://seekingalpha.com/symbol/XPH\" title=\"SPDR S&amp;P Pharmaceuticals ETF\">XPH</a>, <a href=\"https://seekingalpha.com/symbol/PBE\" title=\"Invesco Dynamic Biotechnology &amp; Genome Portfolio ETF\">PBE</a>, <a href=\"https://seekingalpha.com/symbol/FXH\" title=\"First Trust Health Care AlphaDEX ETF\">FXH</a>, <a href=\"https://seekingalpha.com/symbol/FHLC\" title=\"Fidelity MSCI Health Care Index ETF\">FHLC</a>, <a href=\"https://seekingalpha.com/symbol/IHE\" title=\"iShares U.S. Pharmaceuticals ETF\">IHE</a>, <a href=\"https://seekingalpha.com/symbol/RXL\" title=\"ProShares Ultra Health Care ETF\">RXL</a>, <a href=\"https://seekingalpha.com/symbol/LABU\" title=\"Direxion Daily S&amp;P Biotech Bull 3x Shares ETF\">LABU</a>, <a href=\"https://seekingalpha.com/symbol/BBC\" title=\"BioShares Biotechnology Clinical Trials ETF\">BBC</a>, <a href=\"https://seekingalpha.com/symbol/PPH\" title=\"VanEck Vectors Pharmaceutical ETF\">PPH</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229785\" data-linked=\"Healthcare bounces back from Trump tantrum\" data-tweet=\"$MDCO $XLV $IBB - Healthcare bounces back from Trump tantrum https://seekingalpha.com/news/3229785-healthcare-bounces-back-from-trump-tantrum?source=tweet\" data-url=\"https://seekingalpha.com/news/3229785-healthcare-bounces-back-from-trump-tantrum\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229781\" data-ts=\"1481307576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JAGX\" target=\"_blank\">JAGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229781-jaguar-targets-equine-vets-for-neonorm-potential-market-expansion-stokes-shares-35\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jaguar targets equine vets for Neonorm, potential market expansion stokes shares 35%</a></h4><ul>\n<li>Thinly traded nano cap Jaguar Animal Health (<a href=\"https://seekingalpha.com/symbol/JAGX\" title=\"Jaguar Animal Health, Inc.\">JAGX</a> <font color=\"green\">+34.8%</font>) heads north on almost a 5x surge in volume in apparent response to its announcement of its promotional activities related to dehydration treatment <a href=\"http://jaguaranimalhealth.com/neonorm/\" target=\"_blank\">Neonorm </a>at a recent conference of equine (horse) veterinarians.</li>\n<li>The company exhibited Neonorm in distributor Henry Schein's booth then presided over a gathering of 16 prominent equine vets.</li>\n<li>Neonorm Calf, as the names implies, is a treatment for scours in dairy calves. Neonorm Foal is targeted for young horses.</li>\n<li>The company says the addressable market for Neonorm would be significantly expanded if it can demonstrate Neonorm's effectiveness in adult horses.</li>\n<li>\n<a href=\"http://jaguaranimalhealth.com/neonorm/technical-specs/\" target=\"_blank\">Neonorm </a>given to preweaned dairy calves decreases the severity of <a href=\"http://www.cattlenetwork.com/cattle-resources/baby-calf-health/Calf-Scours-Causes-prevention-and-treatment-121277154.html\" target=\"_blank\">scours</a>, an affliction characterized by debilitating diarrhea that kills more than half newborn calves. Non-prescription Neonorm is an extract of a South American tree called <a href=\"http://jaguaranimalhealth.com/neonorm/ethnobotanical-origins/\" target=\"_blank\">Croton lechleri</a>, known as the Dragon's blood tree because of the blood red latex it produces.</li>\n<li>On another note, the company filed an <a href=\"https://www.sec.gov/Archives/edgar/data/1585608/000104746916017087/a2230440zs-1.htm#di78701_use_of_proceeds\" target=\"_blank\">S-1</a> on Wednesday, December 7 registering ~6.7M common shares for sale by current stockholders. The company will receive no proceeds from the sales.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229781\" data-linked=\"Jaguar targets equine vets for Neonorm, potential market expansion stokes shares 35%\" data-tweet=\"$JAGX - Jaguar targets equine vets for Neonorm, potential market expansion stokes shares 35% https://seekingalpha.com/news/3229781-jaguar-targets-equine-vets-for-neonorm-potential-market-expansion-stokes-shares-35?source=tweet\" data-url=\"https://seekingalpha.com/news/3229781-jaguar-targets-equine-vets-for-neonorm-potential-market-expansion-stokes-shares-35\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229777\" data-ts=\"1481306262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229777-cliff-natural-ceo-goncalves-looks-to-trump-to-keep-good-times-rolling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cliff Natural CEO Goncalves looks to Trump to keep good times rolling</a></h4><ul>     <li>Cliffs Natural Resources (<a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs, Inc.\">CLF</a> <font color=\"red\">-5.5%</font>) likely will <a href=\"https://www.bloomberg.com/news/articles/2016-12-09/cliffs-ceo-says-trump-to-keep-good-times-rolling-after-rally\" target=\"_blank\">generate \u201ca lot\u201d of cash next year</a> to help pay down debt, CEO Lourenco Goncalves tells Bloomberg, crediting Pres.-elect Trump\u2019s focus on infrastructure building and a crackdown on unfair trade.</li>     <li>CLF shares had nearly quadrupled through early November amid signs of improving demand and successful  U.S. trade cases against steel imports, and have surged an additional 69% since the election; if Trump implements just part of his promises, \"not only will the country be a  lot better after these things are implemented, but businesses like  Cliffs and all steel mills in the United States will benefit very much,\" the CEO says.</li>     <li>Paying down debt will continue to be the most important use of proceeds  of any cash CLF generates, Goncalves says, adding that he has no  plans to raise equity for now because he does not want to dilute  the shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229777\" data-linked=\"Cliff Natural CEO Goncalves looks to Trump to keep good times rolling\" data-tweet=\"$CLF - Cliff Natural CEO Goncalves looks to Trump to keep good times rolling https://seekingalpha.com/news/3229777-cliff-natural-ceo-goncalves-looks-to-trump-to-keep-good-times-rolling?source=tweet\" data-url=\"https://seekingalpha.com/news/3229777-cliff-natural-ceo-goncalves-looks-to-trump-to-keep-good-times-rolling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>72&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229773\" data-ts=\"1481305870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229773-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IDXG' title='Interpace Diagnostics Group, Inc.'>IDXG</a> <font color='green'>+37%</font>. <a href='https://seekingalpha.com/symbol/INVN' title='InvenSense'>INVN</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/EBS' title='Emergent BioSolutions Inc.'>EBS</a> <font color='green'>+20%</font>. SWC <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/UTI' title='Universal Technical Institute'>UTI</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/PACD' title='Pacific Drilling SA'>PACD</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/ORIG' title='Ocean Rig UDW Inc.'>ORIG</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/SDLP' title='Seadrill Partners, LLC'>SDLP</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/NADL' title='North Atlantic Drilling Ltd.'>NADL</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SCON' title='Superconductor Technologies Inc.'>SCON</a> <font color='red'>-29%</font>. <a href='https://seekingalpha.com/symbol/DLTH' title='Duluth Holdings'>DLTH</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/XTLY' title='Xactly'>XTLY</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/CLSD' title='Clearside Biomedical'>CLSD</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/ORPN' title='Bio Blast Pharma'>ORPN</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a> <font color='red'>-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229773\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$IDXG $INVN $EBS - Midday Gainers / Losers https://seekingalpha.com/news/3229773-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3229773-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229771\" data-ts=\"1481305456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBS\" target=\"_blank\">EBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229771-emergent-bio-nabs-biothrax-contract-valued-up-to-911m-2016-guidance-updated-shares-up-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Emergent Bio nabs BioThrax contract valued up to $911M; 2016 guidance updated; shares up 20%</a></h4><ul>\n<li>Emergent BioSolutions (<a href=\"https://seekingalpha.com/symbol/EBS\" title=\"Emergent BioSolutions Inc.\">EBS</a> <font color=\"green\">+19.6%</font>) inks a follow-on contract with the U.S. Centers for Disease Control and Prevention (CDC) valued at up to $911M to supply ~29.4M doses of anthrax vaccine BioThrax to the Strategic National Stockpile (SNS) through September 2021.</li>\n<li>The company plans to deliver ~9M doses of BioThrax in each of 2017 and 2018, followed by 10M doses in 2019.</li>\n<li>Also, the federal government's Biomedical Advanced Research and Development Authority (BARDA) has issued a notice to procure ~$100M of BioThrax for delivery to the SNS over a period of 24 months. The contract, separate from the CDC's, should be awarded in H1 2017.</li>\n<li>\n<strong>Updated 2016 guidance</strong>: Revenue: $485M - 505M (with Aptevo) and $465M - 485M (without Aptevo); Net Income: $35M - 45M (with) and $50M - 60M (without). The company spun out Aptevo Therapeutics in August.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229771\" data-linked=\"Emergent Bio nabs BioThrax contract valued up to $911M; 2016 guidance updated; shares up 20%\" data-tweet=\"$EBS - Emergent Bio nabs BioThrax contract valued up to $911M; 2016 guidance updated; shares up 20% https://seekingalpha.com/news/3229771-emergent-bio-nabs-biothrax-contract-valued-up-to-911m-2016-guidance-updated-shares-up-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3229771-emergent-bio-nabs-biothrax-contract-valued-up-to-911m-2016-guidance-updated-shares-up-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229768\" data-ts=\"1481304289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZN\" target=\"_blank\">AZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229768-fda-accepts-astrazenecas-marketing-application-for-durvalumab-for-bladder-cancer-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA accepts AstraZeneca&#39;s marketing application for durvalumab for bladder cancer; shares up 4%</a></h4><ul>\n<li>The FDA <a href=\"https://www.sec.gov/Archives/edgar/data/901832/000165495416004704/a4866r.htm\" target=\"_blank\">accepts</a> under Priority Review AstraZeneca's (<a href=\"https://seekingalpha.com/symbol/AZN\" title=\"AstraZeneca Group plc\">AZN</a> <font color=\"green\">+3.7%</font>) Biologics License Application (BLA) seeking approval of durvalumab for the treatment of patients with locally advanced or metastatic urothelial carcinoma whose disease has progressed during or after one line of platinum-based chemo.</li>\n<li>The agency's specific action date (PDUFA) is not provided, but should happen in Q2 2017 considering the six-month review clock.</li>\n<li>Breakthrough Therapy-tagged durvalumab is a human monoclonal antibody that binds to programmed death ligand-1 (PD-L1) which is expressed by some tumors to evade detection by the immune system by binding to PD-1 on cytotoxic T lymphocytes. Blocking the interaction between PD-L1 and PD-1 enhances the immune system's ability to detect and kill cancer cells.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229768\" data-linked=\"FDA accepts AstraZeneca&#39;s marketing application for durvalumab for bladder cancer; shares up 4%\" data-tweet=\"$AZN - FDA accepts AstraZeneca&#39;s marketing application for durvalumab for bladder cancer; shares up 4% https://seekingalpha.com/news/3229768-fda-accepts-astrazenecas-marketing-application-for-durvalumab-for-bladder-cancer-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3229768-fda-accepts-astrazenecas-marketing-application-for-durvalumab-for-bladder-cancer-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229760\" data-ts=\"1481303650\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHFS\" target=\"_blank\">CHFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229760-sunshine-heart-clinging-to-life-shares-up-250-in-two-days\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunshine Heart clinging to life, shares up 250% in two days</a></h4><ul>\n<li>The impact of \"market forces\" are on full display with nano cap Sunshine Heart  (SSH <font color=\"green\">+19%</font>). Shares have jumped 250% since yesterday. The company faces possible delisting from Nasdaq because its share price and stockholders equity are below minimum standards. The company says it is \"working diligently\" to address the situation before the March 20 deadline.</li>\n<li>Underwriters will work their magic here. The company's cash balance at the end of September was only $792K so a capital raise is essential.</li>\n<li>In the company's <a href=\"https://www.sec.gov/Archives/edgar/data/1506492/000110465916161286/a16-21495_1def14a.htm\" target=\"_blank\">proxy materials</a> for its January 9 special stockholders meeting, management is seeking shareholder approval to issue common shares tied to recently sold convertible preferred stock and a 1:20 reverse split of its common shares.</li>\n<li>The conversion of preferred shares will open the door for a possible new offering of convertible stock.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3226340-sunshine-heart-gets-extension-address-nasdaq-listing-deficiency\" target=\"_blank\">Sunshine Heart gets extension to address Nasdaq listing deficiency</a> (Nov. 22)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229760\" data-linked=\"Sunshine Heart clinging to life, shares up 250% in two days\" data-tweet=\"$CHFS - Sunshine Heart clinging to life, shares up 250% in two days https://seekingalpha.com/news/3229760-sunshine-heart-clinging-to-life-shares-up-250-in-two-days?source=tweet\" data-url=\"https://seekingalpha.com/news/3229760-sunshine-heart-clinging-to-life-shares-up-250-in-two-days\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229763\" data-ts=\"1481303095\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INVN\" target=\"_blank\">INVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229763-invensenseplus-27-talks-involving-takeover-tdk-reported\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InvenSense +27%, talks involving takeover by TDK reported</a></h4><ul>\n<li>\n<a href=\"http://www.reuters.com/article/us-invensense-m-a-tdkcorp-exclusive-idUSKBN13Y229?il=0\" target=\"_blank\">Reuters sources</a> have TDK (<a href=\"https://seekingalpha.com/symbol/TTDKY/focus\" target=\"_blank\">TTDKY</a>, <a href=\"https://seekingalpha.com/symbol/TTDKF/focus\" target=\"_blank\">TTDKF</a>) extending a $12 per share (current price $10.55) offer to buy out InvenSense (NYSE:<a href=\"https://seekingalpha.com/symbol/INVN\" title=\"InvenSense\">INVN</a>).</li>\n<li>While negotiations remain fluid, a finalization of terms by the end of the month is claimed targeted.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229763\" data-linked=\"InvenSense +27%, talks involving takeover by TDK reported\" data-tweet=\"$INVN $TTDKY $TTDKF - InvenSense +27%, talks involving takeover by TDK reported https://seekingalpha.com/news/3229763-invensenseplus-27-talks-involving-takeover-tdk-reported?source=tweet\" data-url=\"https://seekingalpha.com/news/3229763-invensenseplus-27-talks-involving-takeover-tdk-reported\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229762\" data-ts=\"1481303080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHAK\" target=\"_blank\">SHAK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229762-breakfast-is-part-of-shake-shack-equation-now\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Breakfast is part of the Shake Shack equation now</a></h4><ul> <li>Shake Shack (NYSE:<a href='https://seekingalpha.com/symbol/SHAK' title='Shake Shack'>SHAK</a>) has a new growth engine with breakfast sandwiches if a <a href=\"http://ny.eater.com/2016/12/7/13872340/shake-shack-penn-station-breakfast-sandwich\" target=\"_blank\">positive review</a>&nbsp;posted by Eater.com is accurate.</li> <li>The upside for the company is that it only offers breakfast service in less than 10% of its outlets and it could launch an all-day breakfast initiative.</li> <li>Shares of SHAK are <font color='green'>up 1.29%</font> to $37.74.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3229762\" data-linked=\"Breakfast is part of the Shake Shack equation now\" data-tweet=\"$SHAK - Breakfast is part of the Shake Shack equation now https://seekingalpha.com/news/3229762-breakfast-is-part-of-shake-shack-equation-now?source=tweet\" data-url=\"https://seekingalpha.com/news/3229762-breakfast-is-part-of-shake-shack-equation-now\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229757\" data-ts=\"1481302756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229757-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/LFVN' title='LifeVantage Corporation'>LFVN</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/MOD' title='Modine Manufacturing Company'>MOD</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/CAAS' title='China Automotive Systems, Inc.'>CAAS</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/NTZ' title='Natuzzi S.p.A.'>NTZ</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3229757\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$FFHL $LFVN $MOD - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3229757-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3229757-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229759\" data-ts=\"1481302722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TECK\" target=\"_blank\">TECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229759-teck-resources-ceo-eyes-hike-and-restructure-for-dividend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teck Resources CEO eyes hike and/or restructure for dividend</a></h4><ul>     <li>Teck Resources (<a href=\"https://seekingalpha.com/symbol/TECK\" title=\"Teck Resources Limited\">TECK</a> <font color=\"red\">-4.8%</font>) will <a href=\"https://www.bloomberg.com/news/articles/2016-12-09/teck-hopes-to-join-glencore-in-boosting-dividends-as-metals-soar\" target=\"_blank\">consider raising its dividend</a> in April as a way to further reward shareholders who already have enjoyed a 6x surge in the shares this year, CEO Don Lindsay tells Bloomberg.</li>     <li>The CEO says Teck generates \u201cwell over\u201d C$1B ($759M) per quarter in cash, and the first priority for the money will be reducing debt to $5B or less, which he says will be achieved in Q1 or soon after; then, the dividend would be a priority for the board, both raising it and potentially changing its structure.</li>     <li>Rather than offer a stable dividend that rises over time with production capacity, Lindsay says shareholders would be better served by a regular base dividend that is \u201ctopped up\u201d at year-end if commodities outperform.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229759\" data-linked=\"Teck Resources CEO eyes hike and/or restructure for dividend\" data-tweet=\"$TECK - Teck Resources CEO eyes hike and/or restructure for dividend https://seekingalpha.com/news/3229759-teck-resources-ceo-eyes-hike-and-restructure-for-dividend?source=tweet\" data-url=\"https://seekingalpha.com/news/3229759-teck-resources-ceo-eyes-hike-and-restructure-for-dividend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229753\" data-ts=\"1481302160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACER\" target=\"_blank\">ACER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229753-opexa-up-almost-50-equity-offering-coming\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Opexa up almost 50%, equity offering coming?</a></h4><ul><li>Nano cap Opexa Therapeutics (OPXA <font color=\"green\">+47.7%</font>) jumps on more than triple normal volume. Shares are up 160% since bottoming at $0.50 on November 9 after the Tcelna flop in a multiple sclerosis study.</li></ul><div class=\"tiny-share-widget\" data-id=\"3229753\" data-linked=\"Opexa up almost 50%, equity offering coming?\" data-tweet=\"$ACER - Opexa up almost 50%, equity offering coming? https://seekingalpha.com/news/3229753-opexa-up-almost-50-equity-offering-coming?source=tweet\" data-url=\"https://seekingalpha.com/news/3229753-opexa-up-almost-50-equity-offering-coming\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229751\" data-ts=\"1481301238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CONN\" target=\"_blank\">CONN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229751-conns-higher-credit-losses-seen-improving\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Conn&#39;s higher with credit losses seen improving</a></h4><ul> <li>SunTrust analyst David Magee thinks Conn's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CONN\" title=\"Conn's, Inc.\">CONN</a>) could see a sharp drop in credit losses in 2017 and 2018.</li> <li>Magee lifts profit estimates on Conn's due to the boost n credit confidence on credit sets a price target of $20 on the Buy-rated retailer.</li> <li>Shares of Conn's are <font color=\"green\">up 5.94%</font> on the day.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3229751\" data-linked=\"Conn&#39;s higher with credit losses seen improving\" data-tweet=\"$CONN - Conn&#39;s higher with credit losses seen improving https://seekingalpha.com/news/3229751-conns-higher-credit-losses-seen-improving?source=tweet\" data-url=\"https://seekingalpha.com/news/3229751-conns-higher-credit-losses-seen-improving\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229737\" data-ts=\"1481300689\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EDGE\" target=\"_blank\">EDGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229737-results-from-successful-study-assessing-edge-therapeutics-lead-product-candidate-in-brain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Results from successful study assessing Edge Therapeutics&#39; lead product candidate in brain hemorrhage published in journal Stroke</a></h4><ul>\n<li>Thinly traded micro cap Edge Therapeutics (<a href=\"https://seekingalpha.com/symbol/EDGE\" title=\"Edge Therapeutics\">EDGE</a> <font color=\"green\">+5.5%</font>) moves up in early trading, albeit on only 16K shares, on the heels of its announcement that results from its Phase 1/2 study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT01893190?term=edge+therapeutics&amp;rank=3\" target=\"_blank\">NEWTON</a>, assessing lead product candidate EG-1962 for the treatment of aneurysmal subarachnoid hemorrhage (aSAH) will appear in the upcoming issue of <em>Stroke</em>.</li>\n<li>NEWTON compared escalating doses of EG-1962 to oral nimodipine, the current standard of care (SOC), in aSAH patients. The study met all primary and secondary endpoints. Results showed 60% of patients treated with EG-1962 achieved a favorable outcome compared to 28% for SOC. Additional benefits attributed to EG-1962 treatment were reductions in vasospasm, delayed cerebral ischemia, reduced use of rescue therapies and shorter stays in the ICU and hospital.</li>\n<li>Fast Track-tagged <a href=\"http://www.edgetherapeutics.com/pipeline/#eg-1962\" target=\"_blank\">EG-1962</a> is microparticle formulation of nimodipine that it is administered through a device used in neurosurgery called an <a href=\"https://en.wikipedia.org/wiki/External_ventricular_drain\" target=\"_blank\">external ventricular drain</a> which is used to relieve elevated intracranial pressure. Its value proposition is the ability to deliver a high concentration of nimodipine directly to the brain as a single dose with sustained drug exposure over 21 days while avoiding the dose-limiting side effects associated with oral nimodipine, a calcium channel blocker used to treat high blood pressure.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229737\" data-linked=\"Results from successful study assessing Edge Therapeutics&#39; lead product candidate in brain hemorrhage published in journal Stroke\" data-tweet=\"$EDGE $PDSB - Results from successful study assessing Edge Therapeutics&#39; lead product candidate in brain hemorrhage published in journal Stroke https://seekingalpha.com/news/3229737-results-from-successful-study-assessing-edge-therapeutics-lead-product-candidate-in-brain?source=tweet\" data-url=\"https://seekingalpha.com/news/3229737-results-from-successful-study-assessing-edge-therapeutics-lead-product-candidate-in-brain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229742\" data-ts=\"1481299774\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229742-21st-century-fox-proposes-to-acquire-sky-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">21st Century Fox proposes to acquire Sky [updated]</a></h4><ul>\n<li>At <a href=\"https://www.bloomberg.com/news/articles/2016-12-09/21st-century-fox-agrees-to-buy-sky?cmpid=socialflow-twitter-business&amp;utm_content=business&amp;utm_campaign=socialflow-organic&amp;utm_source=twitter&amp;utm_medium=social\" target=\"_blank\">£10.75 per share in cash</a>.</li>\n<li>\n<a href=\"http://news.sky.com/story/21st-century-fox-tables-takeover-bid-for-sky-plc-10689526\" target=\"_blank\">Further terms remain under discussion</a> and a finalized deal has so far not transpired.</li>\n<li>21st Century Fox (<a href=\"https://seekingalpha.com/symbol/FOX\" title=\"Twenty-First Century Fox, Inc.\">FOX</a> <font color=\"green\">+2.9%</font>), (<a href=\"https://seekingalpha.com/symbol/FOXA\" title=\"Twenty-First Century Fox, Inc.\">FOXA</a> <font color=\"green\">+2.5%</font>) presently owns a 39% stake in Sky (<a href=\"https://seekingalpha.com/symbol/SKYAY\" title=\"Sky Plc ADR\">OTCPK:SKYAY</a> <font color=\"green\">+20.7%</font>).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229742\" data-linked=\"21st Century Fox proposes to acquire Sky [updated]\" data-tweet=\"$FOX $FOX $FOXA - 21st Century Fox proposes to acquire Sky [updated] https://seekingalpha.com/news/3229742-21st-century-fox-proposes-to-acquire-sky-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3229742-21st-century-fox-proposes-to-acquire-sky-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229721\" data-ts=\"1481299182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229721-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EBS' title='Emergent BioSolutions Inc.'>EBS</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/OPHT' title='Ophthotech Corporation'>OPHT</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/ACIU' title='AC Immune SA'>ACIU</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CLSD' title='Clearside Biomedical'>CLSD</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/IRIX' title='IRIDEX Corporation'>IRIX</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals'>RETA</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/PHMD' title='PhotoMedex, Inc.'>PHMD</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3229721\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$EBS $SGMO $NVCN - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3229721-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3229721-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229743\" data-ts=\"1481299164\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTIP\" target=\"_blank\">NTIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229743-networkminus-1-announces-approval-of-dividend-policy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Network-1 announces approval of dividend policy</a></h4><ul>     <li>Network-1 Technologies (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/NTIP\" title=\"Network-1 Technologies, Inc.\">NTIP</a>) announced that its board has approved the initiation of a dividend policy.</li>     <li>The dividend policy provides for the payment of a regular semi-annual dividend of $0.05/share commencing in 2017 and expects dividend will continue to be paid through March 2020 (the expiration of Network-1's Remote Power Patent) provided that Network-1 continues to receive royalties from licensees of its remote power patent.</li>\n<li>Shares <font color=\"green\">+4.5%</font>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229743\" data-linked=\"Network-1 announces approval of dividend policy\" data-tweet=\"$NTIP - Network-1 announces approval of dividend policy https://seekingalpha.com/news/3229743-networkminus-1-announces-approval-of-dividend-policy?source=tweet\" data-url=\"https://seekingalpha.com/news/3229743-networkminus-1-announces-approval-of-dividend-policy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229735\" data-ts=\"1481298986\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCE-OLD\" target=\"_blank\">CCE-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229735-ripple-effect-from-coca-cola-ceo-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ripple effect from Coca-Cola CEO move</a></h4><ul> <li>Coca-Cola-related names are trading higher after the company announces that Muhtar Kent is stepping down next April to be replaced by COO James Quincey</li> <li>There's a general sense that Quincey may be more open minded to M&amp;A moves.</li> <li>Gainers within the KO extended family include Coca-Cola European Partners (<a href=\"https://seekingalpha.com/symbol/CCE-OLD\" title=\"Coca-Cola European Partners plc\">CCE-OLD</a> <font color=\"green\">+2.4%</font>), Monster Beverage (<a href=\"https://seekingalpha.com/symbol/MNST\" title=\"Monster Beverage Corp.\">MNST</a> <font color=\"green\">+2.1%</font>) and Coca-Cola Bottling Co. (<a href=\"https://seekingalpha.com/symbol/COKE\" title=\"Coca-Cola Consolidated, Inc.\">COKE</a> <font color=\"green\">+1.6%</font>).</li> <li>Beverage M&amp;A targets Primo Water (<a href=\"https://seekingalpha.com/symbol/PRMW\" title=\"Primo Water\">PRMW</a> <font color=\"green\">+1.9%</font>) and National Beverage Corp. (<a href=\"https://seekingalpha.com/symbol/FIZZ\" title=\"National Beverage Corp.\">FIZZ</a> <font color=\"green\">+1.2%</font>) are also showing a little pop.</li> <li>Interrestingly, PepsiCo (<a href=\"https://seekingalpha.com/symbol/PEP\" title=\"PepsiCo Inc.\">PEP</a> <font color=\"green\">+1.4%</font>) is also ahead of broad market averages.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3229681-coca-cola-ceo-step\" target=\"_blank\">Coca-Cola CEO to step down</a> (Dec. 9)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3229689-coca-cola-higher-appointing-new-ceo\" target=\"_blank\">Coca-Cola higher after appointing new CEO</a> (Dec. 9)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229735\" data-linked=\"Ripple effect from Coca-Cola CEO move\" data-tweet=\"$CCE-OLD $CCEP $MNST - Ripple effect from Coca-Cola CEO move https://seekingalpha.com/news/3229735-ripple-effect-from-coca-cola-ceo-move?source=tweet\" data-url=\"https://seekingalpha.com/news/3229735-ripple-effect-from-coca-cola-ceo-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229730\" data-ts=\"1481297545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAL\" target=\"_blank\">AAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229730-airline-stocks-lifted-american-unit-revenue-forecast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Airline stocks lifted by American unit revenue forecast</a></h4><ul> <li>American Airlines Group (<a href=\"https://seekingalpha.com/symbol/AAL\" title=\"American Airlines Group\">AAL</a> <font color=\"green\">+4.1%</font>) rallies after the company lifted it outlook for Q4 unit revenue to -1% to +1% growth vs. -2.5% to -0.5% prior forecast.</li> <li>The airline also expects improved yields, despite the increase in oil prices.</li> <li>United Continental (<a href=\"https://seekingalpha.com/symbol/UAL\" title=\"United Continental Holdings, Inc\">UAL</a> <font color=\"green\">+2.7%</font>), SkyWest (<a href=\"https://seekingalpha.com/symbol/SKYW\" title=\"SkyWest, Inc.\">SKYW</a> <font color=\"green\">+1.9%</font>) and JetBlue (<a href=\"https://seekingalpha.com/symbol/JBLU\" title=\"JetBlue Airways Corporation\">JBLU</a> <font color=\"green\">+1.6%</font>) are also tracking higher on the day off the positive sector read.</li>\n<li>Related ETF: <a href=\"https://seekingalpha.com/symbol/JETS\" title=\"U.S. Global Jets ETF\">JETS</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3229730\" data-linked=\"Airline stocks lifted by American unit revenue forecast\" data-tweet=\"$AAL $AAL $UAL - Airline stocks lifted by American unit revenue forecast https://seekingalpha.com/news/3229730-airline-stocks-lifted-american-unit-revenue-forecast?source=tweet\" data-url=\"https://seekingalpha.com/news/3229730-airline-stocks-lifted-american-unit-revenue-forecast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229728\" data-ts=\"1481296987\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AFL\" target=\"_blank\">AFL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229728-rbc-recommends-moving-from-p-and-c-to-life-insurers-lincoln-national-top-pick\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC recommends moving from P&amp;C to life insurers; Lincoln National a top pick</a></h4><ul>\n<li>An improved outlook for interest rates (higher) and the hope for an easing of the DOL's new fiduciary rule in a Trump administration mean it's time to shift money into the life insurance sector, says RBC's Mark Dwelle.</li>\n<li>P&amp;C insurers face weak pricing expectations, so the focus will be on accident-year margin pressure and the implications for reserves.</li>\n<li>Alongside <a href=\"https://seekingalpha.com/news/3229649-aflac-cut-underperform-rbc-capital\" target=\"_blank\">an earlier-reported downgrade</a> of Aflac (NYSE:<a href=\"https://seekingalpha.com/symbol/AFL\" title=\"Aflac Incorporated\">AFL</a>) to Underperform (stock is now <font color=\"red\">down 2.3%</font>), he cuts RLI Corp. (<a href=\"https://seekingalpha.com/symbol/RLI\" title=\"RLI Corp\">RLI</a> <font color=\"red\">-5.2%</font>) to Underperform as well.</li>\n<li>Downgraded to Sector Perform are Unum (<a href=\"https://seekingalpha.com/symbol/UNM\" title=\"Unum Group\">UNM</a> <font color=\"red\">-1.6%</font>) and Selective Insurance (<a href=\"https://seekingalpha.com/symbol/SIGI\" title=\"Selective Insurance Group, Inc.\">SIGI</a> <font color=\"red\">-4.6%</font>).</li>\n<li>Favored pick in P&amp;C is Chubb (<a href=\"https://seekingalpha.com/symbol/CB\" title=\"Chubb Ltd\">CB</a> <font color=\"red\">-0.2%</font>) as it's a \"top underwriter\" regardless of pricing, and has a clean balance sheet and attractive valuation.</li>\n<li>Upgraded to Outperform are Hartford (<a href=\"https://seekingalpha.com/symbol/HIG\" title=\"Hartford Financial Services Group Inc.\">HIG</a> <font color=\"green\">+0.5%</font>) and Lincoln National (<a href=\"https://seekingalpha.com/symbol/LNC\" title=\"Lincoln National Corporation\">LNC</a> <font color=\"red\">-0.1%</font>), with LNC a Top Pick thanks to its leverage to higher rates and eased DOL rule.</li>\n<li>Top value ideas are AIG (<a href=\"https://seekingalpha.com/symbol/AIG\" title=\"American International Group Inc\">AIG</a> <font color=\"red\">-0.1%</font>)  and Voya Financial (<a href=\"https://seekingalpha.com/symbol/VOYA\" title=\"Voya Financial, Inc.\">VOYA</a> <font color=\"green\">+0.5%</font>). Top growth ideas: Arch (<a href=\"https://seekingalpha.com/symbol/ACGL\" title=\"Arch Capital Group Ltd.\">ACGL</a> <font color=\"green\">+0.6%</font>), Principal Financial (<a href=\"https://seekingalpha.com/symbol/PFG\" title=\"Principal Financial Group, Inc.\">PFG</a> <font color=\"red\">-1.1%</font>). Top small-cap picks: American Equity (<a href=\"https://seekingalpha.com/symbol/AEL\" title=\"American Equity Investment Life Holding Company\">AEL</a> <font color=\"green\">+3.9%</font>), Kinsale Capital (<a href=\"https://seekingalpha.com/symbol/KNSL\" title=\"Kinsale Capital Group, Inc.\">KNSL</a> <font color=\"green\">+1.1%</font>). Top turnaround/self-help picks: MetLife (<a href=\"https://seekingalpha.com/symbol/MET\" title=\"MetLife, Inc.\">MET</a> <font color=\"red\">-0.6%</font>), XL Group (<a href=\"https://seekingalpha.com/symbol/XL\" title=\"XL Group plc\">XL</a> <font color=\"red\">-0.1%</font>). Top defensive play: Marsh &amp; McLennan (<a href=\"https://seekingalpha.com/symbol/MMC\" title=\"Marsh &amp; McLennan Companies, Inc.\">MMC</a>).</li>\n<li>Source: Bloomberg</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229728\" data-linked=\"RBC recommends moving from P&amp;C to life insurers; Lincoln National a top pick\" data-tweet=\"$AFL $AFL $RLI - RBC recommends moving from P&amp;C to life insurers; Lincoln National a top pick https://seekingalpha.com/news/3229728-rbc-recommends-moving-from-p-and-c-to-life-insurers-lincoln-national-top-pick?source=tweet\" data-url=\"https://seekingalpha.com/news/3229728-rbc-recommends-moving-from-p-and-c-to-life-insurers-lincoln-national-top-pick\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229710\" data-ts=\"1481294366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MVIS\" target=\"_blank\">MVIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229710-microvision-prices-common-stock-offering-13m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MicroVision prices common stock offering at $13M</a></h4><ul>\n<li>MicroVision, having <a href=\"https://seekingalpha.com/news/3229587-microvision-declares-common-stock-offering-minus-10_5-percent\" target=\"_blank\">yesterday announced</a> proposal for a public stock offering without specific size, updates this morning on terms for a 12.1M share and $1.07 price per event.</li>\n<li>Estimated net proceeds are approximated at $11.8M and intended for general corporate purposes. Closure of the offering is expected on or around December 14.</li>\n<li>MicroVision (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MVIS\" title=\"Microvision, Inc.\">MVIS</a>) shares are at <font color=\"red\">21% losses</font> early.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229710\" data-linked=\"MicroVision prices common stock offering at $13M\" data-tweet=\"$MVIS - MicroVision prices common stock offering at $13M https://seekingalpha.com/news/3229710-microvision-prices-common-stock-offering-13m?source=tweet\" data-url=\"https://seekingalpha.com/news/3229710-microvision-prices-common-stock-offering-13m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229706\" data-ts=\"1481293579\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229706-sentiment-sours-on-restoration-hardware\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sentiment sours on Restoration Hardware</a></h4><ul> <li>There's a colorful array of words pouring out of Wall Street firms to describe Restoration Hardware's (NYSE:<a href=\"https://seekingalpha.com/symbol/RH\" title=\"RH\">RH</a>) earnings report.</li> <li>Cowen sees \"many shortfalls\" and raises concerns over \"aggressive\" SKU rationalization and says it's \"unclear\" if the business will improve.</li> <li>Telsey calls the retailer's forecast \"disappointing\" and points to \"execution missteps.\"</li> <li>Oppenheimer sees \"risks\" to sales and EPS.</li>\n<li>Sources: CNBC TV and Bloomberg</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3229527-restoration-hardware-beats-0_04-beats-revenue\" target=\"_blank\">Restoration Hardware beats by $0.04, beats on revenue</a> (Dec. 8)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3229543-restoration-hardware-crushed-holiday-guidance-disappoints\" target=\"_blank\">Restoration Hardware crushed after holiday guidance disappoints</a> (Dec. 8)</li> <li>Shares of Restoration Hardware are <font color=\"red\">down 17%</font> premarket to $32.18 to erase their post-election gains.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229706\" data-linked=\"Sentiment sours on Restoration Hardware\" data-tweet=\"$RH - Sentiment sours on Restoration Hardware https://seekingalpha.com/news/3229706-sentiment-sours-on-restoration-hardware?source=tweet\" data-url=\"https://seekingalpha.com/news/3229706-sentiment-sours-on-restoration-hardware\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229705\" data-ts=\"1481293300\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRIX\" target=\"_blank\">IRIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229705-iridex-commences-equity-offering-shares-ease-9-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IRIDEX commences equity offering; shares ease 9% premarket</a></h4><ul>\n<li>IRIDEX (NASDAQ:<a href=\"https://seekingalpha.com/symbol/IRIX\" title=\"IRIDEX Corporation\">IRIX</a>) is down <font color=\"red\">9%</font> premarket on light volume in response to the pricing of its public offering of 1.15M common shares at $14. Underwriters over-allotment is an additional 172.5K shares.</li>\n<li>Net proceeds of ~$15.1M will fund working capital and general corporate purposes.</li>\n<li>Yesterday's close was $15.51.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229705\" data-linked=\"IRIDEX commences equity offering; shares ease 9% premarket\" data-tweet=\"$IRIX - IRIDEX commences equity offering; shares ease 9% premarket https://seekingalpha.com/news/3229705-iridex-commences-equity-offering-shares-ease-9-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3229705-iridex-commences-equity-offering-shares-ease-9-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229703\" data-ts=\"1481293186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229703-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul>\n<li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/IDXG\" title=\"Interpace Diagnostics Group, Inc.\">IDXG</a> <font color=\"green\">+45%</font>. SWC <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/SGYP\" title=\"Synergy Pharmaceuticals, Inc.\">SGYP</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/NAK\" title=\"Northern Dynasty Minerals Ltd\">NAK</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/NVCN\" title=\"Neovasc Inc.\">NVCN</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/FGP\" title=\"Ferrellgas Partners L.P\">FGP</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/ORIG\" title=\"Ocean Rig UDW Inc.\">ORIG</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/FNSR\" title=\"Finisar Corporation\">FNSR</a> <font color=\"green\">+8%</font>. MPEL <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/AVGO\" title=\"Broadcom Limited\">AVGO</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/WYNN\" title=\"Wynn Resorts, Limited\">WYNN</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/LVS\" title=\"Las Vegas Sands Corp.\">LVS</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/BIIB\" title=\"Biogen Inc.\">BIIB</a> <font color=\"green\">+5%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/SCON\" title=\"Superconductor Technologies Inc.\">SCON</a> <font color=\"red\">-28%</font>. <a href=\"https://seekingalpha.com/symbol/MVIS\" title=\"Microvision, Inc.\">MVIS</a> <font color=\"red\">-25%</font>. <a href=\"https://seekingalpha.com/symbol/CLSD\" title=\"Clearside Biomedical\">CLSD</a> <font color=\"red\">-22%</font>. <a href=\"https://seekingalpha.com/symbol/RH\" title=\"RH\">RH</a> <font color=\"red\">-17%</font>. <a href=\"https://seekingalpha.com/symbol/SBGL\" title=\"Sibanye-Stillwater\">SBGL</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/USAC\" title=\"USA Compression Partners, LP\">USAC</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/AIRG\" title=\"Airgain\">AIRG</a> <font color=\"red\">-6%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229703\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$IDXG $SBGL $SGYP-OLD - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3229703-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3229703-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229702\" data-ts=\"1481292948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLSD\" target=\"_blank\">CLSD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229702-clearside-biomedical-launches-equity-offering-shares-slip-19-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clearside Biomedical launches equity offering; shares slip 19% premarket</a></h4><ul>\n<li>Thinly traded micro cap Clearside Biomedical (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CLSD\" title=\"Clearside Biomedical\">CLSD</a>) retreats <font color=\"red\">19%</font> premarket on increased volume in response to its pending $75M public offering of common stock. Price, volume and terms have yet to be announced.</li>\n<li>Net proceeds will fund its pivotal Phase 3 study of suprachoroidal Zuprata for the treatment of macular edema associated with non-infectious uveitis, the initiation of its Phase 3 program of suprachoroidal Zuprata, in combination with Regeneron Pharmaceuticals' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/REGN\" title=\"Regeneron Pharmaceuticals, Inc.\">REGN</a>) Eylea (aflibercept), for the treatment of macular edema associated with retinal vein occlusion, the completion of certain other clinical trials, working capital and general corporate purposes.</li>\n<li>Yesterday's close was $11.53.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229702\" data-linked=\"Clearside Biomedical launches equity offering; shares slip 19% premarket\" data-tweet=\"$CLSD $CLSD $REGN - Clearside Biomedical launches equity offering; shares slip 19% premarket https://seekingalpha.com/news/3229702-clearside-biomedical-launches-equity-offering-shares-slip-19-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3229702-clearside-biomedical-launches-equity-offering-shares-slip-19-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229694\" data-ts=\"1481292080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRO\" target=\"_blank\">FRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229694-frontline-raises-100m-via-13_4m-share-issue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontline raises $100M via ~13.4M-share issue</a></h4><ul>     <li>Frontline (NYSE:<a href=\"https://seekingalpha.com/symbol/FRO\" title=\"Frontline Ltd.\">FRO</a>) <font color=\"red\">-1.5%</font> premarket on news it has raised $100M through the issuance of more than 13.4M common shares at $7.45 each.</li>     <li>FRO's largest shareholder, Hemen Holding, was allocated 10% of the offering, and now owns more than 82.1M shares, equaling a 48.4% stake.</li>     <li>FRO says it will use the proceeds to fund vessel acquisitions and for general corporate purposes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229694\" data-linked=\"Frontline raises $100M via ~13.4M-share issue\" data-tweet=\"$FRO - Frontline raises $100M via ~13.4M-share issue https://seekingalpha.com/news/3229694-frontline-raises-100m-via-13_4m-share-issue?source=tweet\" data-url=\"https://seekingalpha.com/news/3229694-frontline-raises-100m-via-13_4m-share-issue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229690\" data-ts=\"1481292069\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGYP\" target=\"_blank\">SGYP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229690-synergy-pharmas-plecanatide-successful-in-late-stage-ibs-c-study-shares-ahead-17-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synergy Pharma&#39;s plecanatide successful in late-stage IBS-C study; shares ahead 17% premarket</a></h4><ul>\n<li>The <a href=\"https://clinicaltrials.gov/ct2/show/NCT02387359?term=plecanatide&amp;phase=2&amp;rank=5\" target=\"_blank\">first of two Phase 3 clinical trials</a> assessing Synergy Pharmaceuticals' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SGYP\" title=\"Synergy Pharmaceuticals, Inc.\">SGYP</a>) plecanatide for the treatment of adult patients with irritable bowel syndrome with constipation (IBS-C) met its primary endpoint of overall response rate at week 12.</li>\n<li>Specifically, the percentage of Overall Responders in the 3 mg cohort was 21.5% and 24.0% in the 6 mg cohort, both superior to placebo's 14.2% (p=0.009 and p&lt;0.001, respectively). An Overall Responder was defined as one who experienced at least a 30% reduction in worst abdominal pain and at a least one complete spontaneous bowel movement from baseline, in the same week, for at least 50% of the 12 treatment weeks.</li>\n<li>The most common adverse event was diarrhea, which occurred in 3.2% and 3.7% of subjects in the 3 mg and 6 mg groups, respectively.</li>\n<li>Results from a second Phase 3 will be release in the coming weeks.</li>\n<li>Plecanatide is the first investigational therapy designed to replicate the activity of <a href=\"https://en.wikipedia.org/wiki/Uroguanylin\" target=\"_blank\">uroguanylin</a>, a naturally occurring human gastrointestinal peptide, by working locally in the proximal small intestine to stimulate digestive fluid movement and support regular bowel function. It is currently under FDA review for the treatment of chronic idiopathic constipation with an action date of January 29, 2017.</li>\n<li>Shares are up <font color=\"green\">17%</font> premarket on increased volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229690\" data-linked=\"Synergy Pharma&#39;s plecanatide successful in late-stage IBS-C study; shares ahead 17% premarket\" data-tweet=\"$SGYP $SGYP-OLD - Synergy Pharma&#39;s plecanatide successful in late-stage IBS-C study; shares ahead 17% premarket https://seekingalpha.com/news/3229690-synergy-pharmas-plecanatide-successful-in-late-stage-ibs-c-study-shares-ahead-17-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3229690-synergy-pharmas-plecanatide-successful-in-late-stage-ibs-c-study-shares-ahead-17-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>85&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229689\" data-ts=\"1481292025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KO\" target=\"_blank\">KO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229689-coca-cola-higher-after-appointing-new-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coca-Cola higher after appointing new CEO</a></h4><ul> <li>Shares of Coca-Cola (NYSE:<a href=\"https://seekingalpha.com/symbol/KO\" title=\"The Coca-Cola Company\">KO</a>) are <font color=\"green\">up 1.02%</font> to $41.40 after the company announces COO James Quincey will step in for CEO Muhtar Kent in May.</li> <li>Kent will stay on as the Chairman of the Board.</li> <li>There's some speculation that a new CEO at Coca-Cola may be more amenable to a food M&amp;A play to align the company similar to PepsiCo. Over the last five years, PEP shares have outperformed KO shares +57% to +21%.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3229681-coca-cola-ceo-step\" target=\"_blank\">Coca-Cola CEO to step down</a> (Dec. 9)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3229689\" data-linked=\"Coca-Cola higher after appointing new CEO\" data-tweet=\"$KO - Coca-Cola higher after appointing new CEO https://seekingalpha.com/news/3229689-coca-cola-higher-after-appointing-new-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/3229689-coca-cola-higher-after-appointing-new-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229686\" data-ts=\"1481291656\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAL\" target=\"_blank\">AAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229686-american-airlines-updates-q4-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Airlines updates Q4 guidance</a></h4><ul>     <li>American Airlines Group (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AAL\" title=\"American Airlines Group\">AAL</a>) reports revenue passenger miles fell 0.2% in November to 16.8223B. Domestic RPMs fell 1.8% Y/Y.</li>     <li>Capacity was up 0.1% Y/Y to 20.7863B available seat miles. Domestic ASMs decreased 0.6%.</li>     <li>November load factor -30 bps to 80.9%.</li>     <li>YTD load factor -130 bps to 81.8%.</li>     <li>American expects Q4 unit revenue to fall in a range of -1% to +1%. Pre-tax margin of 6% to 8% is seen.</li> <li>AAL <font color=\"green\">+1.87%</font> premarket to $48.95.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229686\" data-linked=\"American Airlines updates Q4 guidance\" data-tweet=\"$AAL - American Airlines updates Q4 guidance https://seekingalpha.com/news/3229686-american-airlines-updates-q4-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3229686-american-airlines-updates-q4-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229668\" data-ts=\"1481289523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLTH\" target=\"_blank\">DLTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229668-duluth-holdings-smacked-down-promotions-and-weather\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Duluth Holdings smacked down by promotions and weather</a></h4><ul> <li>Shares of Duluth Holdings (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DLTH\" title=\"Duluth Holdings\">DLTH</a>) dive after the retailer lowers full-year guidance.</li> <li>The company now sees FY16 revenue of $360M-$370M vs. $370M-$380M prior. EBITDA of $34M-$38M is anticipated vs. $40M-$42.5M prior.</li> <li>\"Unseasonable weather, coupled with a highly promotional environment, continued into early fourth quarter,\" notes CEO Stephanie Pugliese.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3229537-duluth-holdings-beats-0_01-misses-revenue\" target=\"_blank\">Duluth Holdings beats by $0.01, misses on revenue</a> (Dec. 8)</li> <li>DLTH <font color=\"red\">-16.71%</font> premarket to $30.85 after gaining over 9% yesterday.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229668\" data-linked=\"Duluth Holdings smacked down by promotions and weather\" data-tweet=\"$DLTH - Duluth Holdings smacked down by promotions and weather https://seekingalpha.com/news/3229668-duluth-holdings-smacked-down-promotions-and-weather?source=tweet\" data-url=\"https://seekingalpha.com/news/3229668-duluth-holdings-smacked-down-promotions-and-weather\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229665\" data-ts=\"1481289127\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESRX\" target=\"_blank\">ESRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229665-express-scripts-trying-to-claw-back-from-citron-stoked-sell-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Express Scripts trying to claw back from Citron-stoked sell-off</a></h4><ul>\n<li>Express Scripts (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ESRX\" title=\"Express Scripts, Inc.\">ESRX</a>) is up <font color=\"green\">2%</font> premarket on light volume. Late yesterday, shares sold off on comments by short seller Andrew Left that the company was the \"Philidor of the pharma industry.\"</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3229616-express-scripts-comes-fire\" target=\"_blank\">Express Scripts comes under fire</a> (Dec. 9)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229665\" data-linked=\"Express Scripts trying to claw back from Citron-stoked sell-off\" data-tweet=\"$ESRX - Express Scripts trying to claw back from Citron-stoked sell-off https://seekingalpha.com/news/3229665-express-scripts-trying-to-claw-back-from-citron-stoked-sell-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3229665-express-scripts-trying-to-claw-back-from-citron-stoked-sell-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229659\" data-ts=\"1481288476\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229659-positive-early-stage-data-on-alzheimers-candidate-stokes-biogen-shares-up-4-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Positive early-stage data on Alzheimer&#39;s candidate stokes Biogen; shares up 4% premarket</a></h4><ul>\n<li>Biogen (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BIIB\" title=\"Biogen Inc.\">BIIB</a>) is up <font color=\"green\">4%</font> premarket on average volume in response to its presentation of positive data from a Phase 1 study of Alzheimer's disease candidate aducanumab at the CTAD meeting in San Diego.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3229511-biogen-perks-leaked-trial-data-alzheimers-candidate-aducanumab\" target=\"_blank\">Biogen perks up on leaked trial data on Alzheimer's candidate aducanumab</a> (Dec. 8)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229659\" data-linked=\"Positive early-stage data on Alzheimer&#39;s candidate stokes Biogen; shares up 4% premarket\" data-tweet=\"$BIIB - Positive early-stage data on Alzheimer&#39;s candidate stokes Biogen; shares up 4% premarket https://seekingalpha.com/news/3229659-positive-early-stage-data-on-alzheimers-candidate-stokes-biogen-shares-up-4-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3229659-positive-early-stage-data-on-alzheimers-candidate-stokes-biogen-shares-up-4-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229655\" data-ts=\"1481288429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LVS\" target=\"_blank\">LVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229655-macau-stocks-re-energized-after-withdrawal-rules-clarified\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macau stocks re-energized after withdrawal rules clarified</a></h4><ul> <li>Officials in Macau clarify that ATM card transactions have been limited to 5K patacas per transaction, but there is no change to the daily limit as reported yesterday by South China Morning Post.</li>\n<li>Shares of Las Vegas Sands (NYSE:<a href=\"https://seekingalpha.com/symbol/LVS\" title=\"Las Vegas Sands Corp.\">LVS</a>) are <font color=\"green\">up 8%</font> in premarket trading to take back much of the ground lost yesterday.</li> <li>Wynn Resorts (NASDAQ:<a href=\"https://seekingalpha.com/symbol/WYNN\" title=\"Wynn Resorts, Limited\">WYNN</a>) and Melco Crown (MPEL) are <font color=\"green\">up 6%</font> and MGM Resorts (NYSE:<a href=\"https://seekingalpha.com/symbol/MGM\" title=\"MGM Resorts International\">MGM</a>) has moved <font color=\"green\">4% higher</font>.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3229504-macau-stocks-stung-beijing-crackdown-atm-withdrawals\" target=\"_blank\">Macau stocks stung by Beijing crackdown on ATM withdrawals</a> (Dec. 8)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3229612-macau-outline-policy-casino-shares-tumble\" target=\"_blank\">Macau to outline policy after casino shares tumble</a> (Dec. 9)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3229655\" data-linked=\"Macau stocks re-energized after withdrawal rules clarified\" data-tweet=\"$LVS $LVS $WYNN - Macau stocks re-energized after withdrawal rules clarified https://seekingalpha.com/news/3229655-macau-stocks-re-energized-after-withdrawal-rules-clarified?source=tweet\" data-url=\"https://seekingalpha.com/news/3229655-macau-stocks-re-energized-after-withdrawal-rules-clarified\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229645\" data-ts=\"1481286372\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DTEA\" target=\"_blank\">DTEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229645-davidstea-lower-after-guidance-falls-short\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DavidsTea lower after guidance falls short</a></h4><ul> <li>DavidsTea (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DTEA\" title=\"DAVIDs TEA\">DTEA</a>) reports a slightly larger loss for Q3 than anticipated amid what it calls a \"challenging\" backdrop.</li> <li>The company sees Q4 revenue of C$84.0M-C$88.0M vs.C$89.6M consensus.</li> <li>Christine Bullen is introduced as the new interim President and CEO.</li> <li>Ratings actions: BMO lowers to Market Perform with a $9 PT. William Blair lowers to Market Perform.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3229524-davids-tea-reports-q3-results\" target=\"_blank\">DAVIDs TEA reports Q3 results</a> (Dec. 8)</li> <li>DTEA <font color=\"red\">-3.23%</font> premarket to $9.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229645\" data-linked=\"DavidsTea lower after guidance falls short\" data-tweet=\"$DTEA - DavidsTea lower after guidance falls short https://seekingalpha.com/news/3229645-davidstea-lower-after-guidance-falls-short?source=tweet\" data-url=\"https://seekingalpha.com/news/3229645-davidstea-lower-after-guidance-falls-short\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229644\" data-ts=\"1481286371\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGL\" target=\"_blank\">SBGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229644-sibanye-gold-to-buy-stillwater-mining-for-2_2b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sibanye Gold to buy Stillwater Mining for $2.2B</a></h4><ul>     <li>Stillwater Mining (SWC) <font color=\"green\">+20.2%</font> premarket after South Africa's Sibanye Gold (NYSE:<a href=\"https://seekingalpha.com/symbol/SBGL\" title=\"Sibanye-Stillwater\">SBGL</a>) agrees to acquire the U.S.-based miner of platinum and palladium for $2.2B.</li>     <li>The $18/share deal price represents a 23% premium to its closing price yesterday.</li>     <li>The purchase is SBGL's third platinum acquisition since late 2015 but its first outside of South Africa, and would make the company, which until last year was solely a gold miner, the world\u2019s third largest platinum producer.</li>     <li>SWC is the only U.S. miner of platinum group metals and the largest primary producer of the metals outside of South Africa and Russia.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229644\" data-linked=\"Sibanye Gold to buy Stillwater Mining for $2.2B\" data-tweet=\"$SBGL - Sibanye Gold to buy Stillwater Mining for $2.2B https://seekingalpha.com/news/3229644-sibanye-gold-to-buy-stillwater-mining-for-2_2b?source=tweet\" data-url=\"https://seekingalpha.com/news/3229644-sibanye-gold-to-buy-stillwater-mining-for-2_2b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":52,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}